{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:40:16Z","timestamp":1782859216190,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Huntington\u2019s disease (HD) is a progressive neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) trinucleotide repeat on chromosome 4. Exploring sex-related differences in disease manifestation may improve understanding and guide more tailored therapeutic and supportive interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate sex differences in the clinical presentation and functional outcomes in a single-center HD cohort, including employment status and use of supportive therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 102 patients with HD who were regularly seen at the Department of Neurology, Medical University of Innsbruck. Exact CAG repeat length was available for 101 participants. Multinomial logistic regression was applied to assess symptom distribution, access to neurorehabilitation, and the impact on employment status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 44 men and 58 women with genetically confirmed Huntington\u2019s Disease. Among participants with available CAG data (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009101), there was no difference in CAG-Repeat length between male and female patients as well as no differences in the onset of motor or non-motor symptoms (all p-values\u2009&gt;\u20090.05). We found that irritability was significantly more prevalent in female patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033). Moreover, women were significantly less likely to be employed than men (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). No sex differences were observed in the utilization of non-pharmacological therapies such as physiotherapy, occupational therapy, speech therapy, or psychotherapy (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Female patients with HD showed higher rates of irritability and lower workforce participation, suggesting clinically relevant sex-related differences. These findings highlight the importance of considering sex as a factor in both clinical management and social support strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04184-3","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:04:59Z","timestamp":1768039499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bridging the gap: sex-specific differences in Huntington\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Greta","family":"Hemicker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Schwarzov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Labrecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clancy","family":"Cerejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Peball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mahlknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atbin","family":"Djamshidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Seppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-3044","authenticated-orcid":false,"given":"Beatrice","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"9557","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369(9557):218\u201328.","journal-title":"Lancet"},{"key":"4184_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.","journal-title":"Orphanet J Rare Dis"},{"issue":"16","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG. From pathogenesis to therapeutics: A review of 150 years of huntington\u2019s disease research. Int J Mol Sci. 2023;24(16):13021.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4184_CR4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00415-015-7900-7","volume":"262","author":"PREDICT-HD The","year":"2015","unstructured":"The PREDICT-HD, Investigators, Coordinators of the Huntington Study Group, Liu D, Long JD, Zhang Y, Raymond LA, Marder K, et al. Motor onset and diagnosis in huntington disease using the diagnostic confidence level. J Neurol. 2015;262(12):2691\u20138.","journal-title":"J Neurol"},{"issue":"2","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Unified Huntington\u2019s disease rating scale","year":"1996","unstructured":"Unified Huntington\u2019s disease rating scale. Reliability and consistency. Mov Disord. 1996;11(2):136\u201342.","journal-title":"Mov Disord"},{"issue":"3","key":"4184_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mdc3.13178","volume":"8","author":"S Hentosh","year":"2021","unstructured":"Hentosh S, Zhu L, Patino J, Furr JW, Rocha NP, Furr Stimming E. Sex differences in huntington\u2019s disease: evaluating the Enroll-HD database. Mov Disord Clin Pract. 2021;8(3):420\u20136.","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","volume":"19","author":"D Zielonka","year":"2013","unstructured":"Zielonka D, Marinus J, Roos RAC, De Michele G, Di Donato S, Putter H, et al. The influence of gender on phenotype and disease progression in patients with huntington\u2019s disease. Parkinsonism Relat Disord. 2013;19(2):192\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"4184_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","volume":"49","author":"D Zielonka","year":"2018","unstructured":"Zielonka D, Ren M, De Michele G, Roos RAC, Squitieri F, Bentivoglio AR, et al. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with huntington\u2019s disease. Parkinsonism Relat Disord. 2018;49:42\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"4184_CR9","doi-asserted-by":"crossref","unstructured":"Ullah MF, Ahmad A, Bhat SH, Abu-Duhier FM, Barreto GE, Ashraf GM. Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders. Neurosci Biobehav Rev. 2019 July;102:95\u2013105.","DOI":"10.1016\/j.neubiorev.2019.04.003"},{"key":"4184_CR10","doi-asserted-by":"publisher","unstructured":"Yao J, Feng G, Shao G, Wang Z, Mendizabal A, Telesca D et al. Interplay Between Sex and Cytosine-Adenine-Guanine-Age Product Score in Huntington\u2019s Disease: Clinical and Neuroimaging Perspectives. Mov Disord [Internet]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/mds.70064. cited 23 Sept 2025.","DOI":"10.1002\/mds.70064"},{"key":"4184_CR11","doi-asserted-by":"publisher","unstructured":"Bilney B, Morris ME, Perry A. Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with huntington\u2019s disease: a systematic review [Internet]. Available from: https:\/\/journals.sagepub.com\/doi\/epdf\/https:\/\/doi.org\/10.1177\/0888439002250448.\u00a0cited 4 Feb 2025.","DOI":"10.1177\/0888439002250448"},{"key":"4184_CR12","doi-asserted-by":"crossref","unstructured":"Fritz NE, Rao AK, Kegelmeyer D, Kloos A, Busse M, Hartel L et al. Physical therapy and exercise interventions in huntington\u2019s disease: a mixed methods systematic review. J Huntingt Dis 2017 Sept 29;6(3):217\u201335.","DOI":"10.3233\/JHD-170260"},{"issue":"4","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JHD-220549","volume":"11","author":"NE Fritz","year":"2022","unstructured":"Fritz NE, Kegelmeyer DA, Rao AK, Quinn L, Kloos AD. Clinical decision trees to guide physical therapy management of persons with huntington\u2019s disease. J Huntingt Dis. 2022;11(4):435\u201353.","journal-title":"J Huntingt Dis"},{"key":"4184_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.parkreldis.2022.02.022","volume":"96","author":"KF Van Der Zwaan","year":"2022","unstructured":"Van Der Zwaan KF, Mentink MDC, Jacobs M, Roos RAC, De Bot ST. Huntington\u2019s disease influences employment before and during clinical manifestation: A systematic review. Parkinsonism Relat Disord. 2022;96:100\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"4184_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26012","volume":"29","author":"CA Ross","year":"2014","unstructured":"Ross CA, Pantelyat A, Kogan J, Brandt J. Determinants of functional disability in huntington\u2019s disease: role of cognitive and motor dysfunction. Mov Disord. 2014;29(11):1351\u20138.","journal-title":"Mov Disord"},{"key":"4184_CR16","unstructured":"Enroll-HD-Plus-User-Guide-2016-10-R1.pdf [Internet]. Available from: https:\/\/www.enroll-hd.org\/enrollhd_documents\/2016-10-R1\/Enroll-HD-Plus-User-Guide-2016-10-R1.pdf.\u00a0cited 1 Apr 2025."},{"issue":"1","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.neuropsych.13070169","volume":"27","author":"J Callaghan","year":"2015","unstructured":"Callaghan J, Stopford C, Arran N, Boisse MF, Coleman A, Santos RD, et al. Reliability and factor structure of the short problem behaviors assessment for huntington\u2019s disease (PBA-s) in the TRACK-HD and REGISTRY studies. J Neuropsychiatry Clin Neurosci. 2015;27(1):59\u201364.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"4184_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, Macdonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in huntington\u2019s disease. Ann Neurol. 1997;41(5):689\u201392.","journal-title":"Ann Neurol"},{"issue":"7","key":"4184_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS, et al. Indexing disease progression at study entry with individuals at-risk for huntington disease. Am J Med Genet B Neuropsychiatr Genet. 2011;156(7):751\u201363.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"4184_CR20","unstructured":"Statistik Austria. Statistik Austria. (2025). Arbeitsmarkt \u2013 QSB Q2 2025 [PDF]. Satatistik Austria. https:\/\/www.statistik.at\/fileadmin\/publications\/Arbeitsmarkt-QSB-Q2-2025_barrierefrei.pdf."},{"key":"4184_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12883-019-1556-3","volume":"19","author":"C Ohlmeier","year":"2019","unstructured":"Ohlmeier C, Saum KU, Galetzka W, Beier D, Gothe H. Epidemiology and health care utilization of patients suffering from huntington\u2019s disease in germany: real world evidence based on German claims data. BMC Neurol. 2019;19:318.","journal-title":"BMC Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04184-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:33:28Z","timestamp":1781627608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04184-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04184-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data analyzed in this retrospective study were obtained from the Enroll-HD study, which was approved by the local ethics committee of the Medical University Innsbruck. (EK Nr.:1073\/2017). Written informed consent was obtained from all individual participants included in the study prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}